AVITA Medical, Inc.
RCEL· Nasdaq
Released Aug 26, 2021, after the close
Source filing unavailable
| Metric | Q2 2021 | Q2 2019 |
|---|---|---|
| Revenue | $10.30M | $1.04M |
| Net Income | -$4.72M | -$6.27M |
| EPS Diluted | $0.19 | -$0.44 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
AVITA Medical, Inc. · CIK 1762303 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
+9.2% from the close of Aug 24, 2021 to the close of Aug 30, 2021, the first after the release.